ONVO Organovo Holdings Inc
Price (delayed)
$0.369
Market cap
$6.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.85
Enterprise value
$6.45M
Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's
Highlights
The EPS has soared by 61% year-on-year and by 20% since the previous quarter
The net income is up by 35% year-on-year
ONVO's gross profit has dropped by 52% year-on-year but it is up by 17% since the previous quarter
The revenue has contracted by 50% YoY but it has grown by 18% from the previous quarter
The equity has dropped by 94% year-on-year and by 90% since the previous quarter
ONVO's quick ratio has plunged by 86% YoY and by 68% from the previous quarter
Key stats
What are the main financial stats of ONVO
Market
Valuations
Earnings
Shares outstanding
17.45M
Market cap
$6.44M
Enterprise value
$6.45M
Price to earnings (P/E)
N/A
Price to book (P/B)
15.58
Price to sales (P/S)
54.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
52.9
Revenue
$122,000
Gross profit
$117,000
Operating income
-$12.56M
Net income
-$12.39M
EBIT
-$12.38M
EBITDA
-$12.1M
Free cash flow
-$10.11M
Per share
Balance sheet
Liquidity
EPS
-$0.85
EPS diluted
-$0.85
Free cash flow per share
-$0.56
Book value per share
$0.02
Revenue per share
$0.01
TBVPS
$0.21
Total assets
$3.84M
Total liabilities
$3.48M
Debt
$1.32M
Equity
$364,000
Working capital
-$837,000
Debt to equity
3.62
Current ratio
0.72
Quick ratio
0.45
Net debt/EBITDA
0
Margins
Efficiency
Dividend
EBITDA margin
-9,919.7%
Gross margin
95.9%
Net margin
-10,151.6%
Operating margin
-10,293.4%
Return on assets
-187.5%
Return on equity
-346.3%
Return on invested capital
-567%
Return on capital employed
-1,364.7%
Return on sales
-10,145.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ONVO stock price
How has the Organovo Holdings stock price performed over time
Intraday
-2.61%
1 week
-4.4%
1 month
-3.91%
1 year
-63.1%
YTD
-19.77%
QTD
-19.77%
Financial performance
How have Organovo Holdings's revenue and profit performed over time
Revenue
$122,000
Gross profit
$117,000
Operating income
-$12.56M
Net income
-$12.39M
Gross margin
95.9%
Net margin
-10,151.6%
ONVO's gross profit has dropped by 52% year-on-year but it is up by 17% since the previous quarter
The revenue has contracted by 50% YoY but it has grown by 18% from the previous quarter
The operating income has grown by 36% YoY
The net income is up by 35% year-on-year
Growth
What is Organovo Holdings's growth rate over time
Valuation
What is Organovo Holdings stock price valuation
P/E
N/A
P/B
15.58
P/S
54.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
52.9
The EPS has soared by 61% year-on-year and by 20% since the previous quarter
The stock's price to book (P/B) is 140% more than its last 4 quarters average of 6.5
The equity has dropped by 94% year-on-year and by 90% since the previous quarter
The revenue has contracted by 50% YoY but it has grown by 18% from the previous quarter
The P/S is 45% below the last 4 quarters average of 99.1
Efficiency
How efficient is Organovo Holdings business performance
The ROE has plunged by 89% YoY and by 39% from the previous quarter
ONVO's return on assets is down by 35% year-on-year and by 18% since the previous quarter
The ROS has declined by 29% year-on-year but it has increased by 17% since the previous quarter
ONVO's return on invested capital is down by 25% since the previous quarter
Dividends
What is ONVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ONVO.
Financial health
How did Organovo Holdings financials performed over time
The total assets is 10% greater than the total liabilities
ONVO's quick ratio has plunged by 86% YoY and by 68% from the previous quarter
ONVO's current ratio has shrunk by 80% YoY and by 64% QoQ
The equity has dropped by 94% year-on-year and by 90% since the previous quarter
ONVO's debt is down by 15% since the previous quarter and by 12% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.